Postoperative survival for patients with thymoma complicating myasthenia gravis—preliminary retrospective results of the ChART database
Authors:
- Fangrui WangFWFangrui Wang
- Liewen PangLPLiewen Pang
- Jianhua FuJFJianhua Fu
- Yi ShenYSYi Shen
- Yucheng WeiYWYucheng Wei
- Lijie TanLTLijie Tan
- Peng ZhangPZPeng Zhang
- Yongtao HanYHYongtao Han
- Chun ChenCCChun Chen
- Renquan ZhangRZRenquan Zhang
- Yin LiYLYin Li
- Keneng ChenKCKeneng Chen
- 1 April 2016
- journal article
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 8 (4) , 711-717
Abstract
Background: It is so far not clear that how myasthenia gravis (MG) affected the prognosis of thymoma patients. The aim of this assay is to compare the postoperative survival between patients with thymoma only and those with both thymoma and MG. Methods: The Chinese Alliance for Research in Thymomas (ChART) registry recruited patients with thymoma from 18 centers over the country on an intention to treat basis from 1992 to 2012. Two groups were formed according to whether the patient complicated MG. Demographic and clinical data were reviewed, patients were followed and their survival status were analyzed. Results: There were 1,850 patients included in this study, including 421 with and 1,429 without MG. Complete thymectomy were done in 91.2% patients in MG group and 71.0% in non-MG group (Pvs. 88%; 83% vs. 81%, P=0.034) respectively. The survival rate was significantly higher in patients with MG when the Masaoka staging was 3/4 (P=0.003). Among patients with advanced stage thymoma (stage 3, 4a, 4b), the constituent ratios of 3, 4a, 4b were similar between MG and non-MG group. Histologically, however, there were significantly more proportion of AB/B1/B2/B3 in the MG group while there were more C in the non-MG group (P=0.000). Univariate analyses for all patients showed that MG, WHO classification, Masaoka stage, surgical approach, chemotherapy and radiotherapy and resectability were significant factors, and multivariate analysis showed WHO classification, Masaoka stage, and resectability were strong independent prognostic indicators. Conclusions: Although MG is not an independent prognostic factor, the survival of patients with thymoma was superior when MG was present, especially in late Masaoka stage patients. Possible reasons included early diagnosis of the tumor, better histologic types, an overall higher R0 resection and less recurrence.Keywords
This publication has 7 references indexed in Scilit:
- Thymoma and inter-relationships between clinical variables: a multicentre study in 537 patientsEuropean Journal of Cardio-Thoracic Surgery, 2014
- Thymoma: inter-relationships among World Health Organization histology, Masaoka staging and myasthenia gravis and their independent prognostic significance: a single-centre experienceEuropean Journal of Cardio-Thoracic Surgery, 2011
- Thymoma and Myasthenia Gravis: A Clinical Study of 1,089 Patients From JapanThe Annals of Thoracic Surgery, 2005
- Prognostic significance of thymomas in patients with myasthenia gravisThe Annals of Thoracic Surgery, 2002
- Results of surgical treatment of thymomas with special reference to the involved organsThe Journal of Thoracic and Cardiovascular Surgery, 1999
- Thymoma: Results of 241 operated casesThe Annals of Thoracic Surgery, 1991
- Thymectomy in myasthenia gravis *1Results of 662 cases operated upon in 15 yearsEuropean Journal of Cardio-Thoracic Surgery, 1989